748132-Awarded - Portugal – Antineoplastic and immunomodulating agents – 251G001445 - INFLIXIMAB 100 MG INJ BIOSSIMILAR (ZESSL)

World Biggest Tenders Source

This tender with title 748132-Awarded - Portugal – Antineoplastic and immunomodulating agents – 251G001445 - INFLIXIMAB 100 MG INJ BIOSSIMILAR (ZESSL) -- Contract Value: 348 000,00 EUR has been published on Bidding Source portal dated 12 Nov 2025 for the country of Portugal. It has been categorized on Antineoplastic and immunomodulating agents. For similar tenders you can see tenders mentioned below of this page.

Contract Value: 348 000,00 EUR

General Information

Portugal

Tender Title :

748132-Awarded - Portugal – Antineoplastic and immunomodulating agents – 251G001445 - INFLIXIMAB 100 MG INJ BIOSSIMILAR (ZESSL)
Contract Value: 348 000,00 EUR

Tender Type :

Contract Award

Reference No. :

748132

Country :

Portugal

Publish Date :

12 Nov 2025

Notice Language :

English

Tender Categories (CPVs) :

Antineoplastic and immunomodulating agents

Full Tender Details :

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

710151-Awarded - Portugal – Antineoplastic and immunomodulating agents – 251G001459 -USTECINUMAB 45 MG SOL INJ -- <b>Contract Value: 321 280,00 EUR</b> Portugal 711196-Awarded - Portugal – Antineoplastic and immunomodulating agents – 251G001449 - C.Central Medicamentos 2025 -1729/2025- NATALIZUMAB -- <b>Contract Value: 240 800,00 EUR</b> Portugal 691045-Awarded - Portugal – Antineoplastic and immunomodulating agents – 2023/0481 - AXICABTAGENE CILOLEUCEL [0.4 - 2 X10E8 CÉLULAS DISPERSÃO INJ SACO] Portugal 691487-Awarded - Portugal – Antineoplastic and immunomodulating agents – 2023/0491 - DURVALUMAB [50 MG/ ML 10 ML FRS] Portugal 691570-Awarded - Portugal – Antineoplastic and immunomodulating agents – 2023/0481 - AXICABTAGENE CILOLEUCEL [0.4 - 2 X10E8 CÉLULAS DISPERSÃO INJ SACO] Portugal 692007-Awarded - Portugal – Antineoplastic and immunomodulating agents – 2023/0491 - OFATUMUMAB [20 MG/0.4 ML SOL INJ CANETA] Portugal 692499-Awarded - Portugal – Antineoplastic and immunomodulating agents – 2023/0491 - BLINATUMOMAB [38.5 µG PÓ CONC SOL SOL INJ FRS] Portugal 692725-Awarded - Portugal – Antineoplastic and immunomodulating agents – 2023/0481 - AXICABTAGENE CILOLEUCEL [0.4 - 2 X10E8 CÉLULAS DISPERSÃO INJ SACO] Portugal 693204-Awarded - Portugal – Antineoplastic and immunomodulating agents – 2023/0491 - CANACINUMAB [150 MG/ML SOL INJ FRS] Portugal 693795-Awarded - Portugal – Antineoplastic and immunomodulating agents – 2023/0491 - LANADELUMAB [300 MG/2 ML SOL INJ SERINGA] Portugal

748132-Awarded - Portugal – Antineoplastic and immunomodulating agents – 251G001445 - INFLIXIMAB 100 MG INJ BIOSSIMILAR (ZESSL)

Contract Value: 348 000,00 EUR

General Information

Portugal

Similar Tenders

Antineoplastic and immunomodulating agents Tenders

Portugal Tenders

Europe Tenders

Tenders

info@biddingsource.com